Safety of Imprime PGG, a novel innate immune cell modulator, in adults with stage IV non-small cell lung cancer: an integrated analysis of two randomized phase 2 studies.

3071 Background: Imprime PGG (IPGG; beta-1,3/1,6 glucan), a yeast-derived pathogen-associated molecular pattern (PAMP), can prime innate immune effector cells to kill cancer cells opsonized by ther...